Traumatic Brain Injury Market Report 2026

The traumatic brain injury market size has grown strongly in recent years. It will grow from $2.96 billion in 2025 to $3.21 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to increase in sports-related and accident-induced tbis, expansion of neurosurgical capabilities, development of rehabilitation protocols, improved survival rates in severe injuries, growth in trauma center networks.

The traumatic brain injury market size is expected to see strong growth in the next few years. It will grow to $4.6 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to advancement of neuroprotective therapies, rising investments in rehabilitation technologies, growing demand for long-term tbi care, expansion of home-based rehabilitation solutions, increasing integration of digital therapy platforms. Major trends in the forecast period include increasing adoption of multidisciplinary tbi treatment approaches, rising use of advanced neurorehabilitation therapies, growing integration of monitoring and imaging devices, expansion of long-term cognitive rehabilitation programs, enhanced focus on personalized treatment plans.

The increasing number of road injuries is expected to drive the growth of the traumatic brain injury (TBI) market in the coming years. Road injuries are physical harms that occur due to accidents on streets, highways, and other transportation routes. The rise in road injuries contributes to a higher incidence of traumatic brain injuries, as collisions often cause sudden impacts to the head, resulting in neurological damage. TBI treatments aid recovery by minimizing complications, improving cognitive function, and enhancing long-term patient outcomes. For example, in April 2024, according to the U.S. Department of Transportation, roadway fatalities in the United States reached 40,990 in 2023, reflecting a persistently high level of roadway injury severity. Therefore, the rising road injuries are fueling the growth of the traumatic brain injury market.

Key companies in the traumatic brain injury market are developing innovative therapies and tests, such as VIDAS TBI (GFAP, UCH-L1), to address evolving patient needs. Novel treatments and diagnostic tests for TBI are continually being researched to improve outcomes and quality of life for affected individuals. For example, in October 2023, bioMérieux, a France-based in vitro diagnostics company, launched VIDAS TBI (GFAP, UCH-L1), a blood test designed to support assessment of patients with mild traumatic brain injury (mTBI) using a combination of brain biomarkers: GFAP and UCH-L1. This accurate and objective tool helps reduce unnecessary head CT scans for mTBI patients and decreases Emergency Department overcrowding by predicting the absence of acute intracranial lesions (ICL) after head trauma.

In January 2023, Natus Medical Incorporated, a US-based medical device company specializing in neurodiagnostics and brain monitoring, acquired Micromed Holding SAS for an undisclosed amount. This acquisition enables Natus to expand its neurophysiology portfolio by integrating Micromed’s EEG, ICU brain monitoring, and operating-room neurodiagnostic systems, strengthening capabilities relevant to traumatic brain injury assessment. Micromed Holding SAS is a France-based company providing neurodiagnostic and neuromonitoring devices for brain health assessment and care.

Major companies operating in the traumatic brain injury market are Medtronic plc, Stryker Corporation, Elekta AB, Integra LifeSciences Holdings Corp., Natus Medical Inc., Nihon Kohden Corporation, Raumedic AG, Qure.ai, Compumedics Ltd., Synaptive Medical Inc., BrainScope Company Inc., Soterix Medical Inc., Neural Analytics Inc., InfraScan Inc., NanoDx Inc., NeuroTrauma Sciences, Oculogica Inc., PathMaker Neurosystems Inc., Pinteon Therapeutics Inc., Abliva AB, QuesGen Systems Inc., Neural Analytics Inc.

North America was the largest region in the traumatic brain injury market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the traumatic brain injury market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the traumatic brain injury market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the traumatic brain injury market by increasing costs of imported imaging systems, monitoring devices, rehabilitation equipment, and pharmaceutical inputs used in acute and post-acute care. North America and Europe face significant cost impacts due to dependence on advanced medical device imports, while Asia-Pacific experiences pricing pressure on treatment expansion. These tariffs raise treatment costs and slow infrastructure upgrades. At the same time, they encourage domestic production of rehabilitation devices, local sourcing of medical equipment, and stronger regional healthcare manufacturing capabilities.

The traumatic brain injury market research report is one of a series of new reports that provides traumatic brain injury market statistics, including traumatic brain injury industry global market size, regional shares, competitors with a traumatic brain injury market share, detailed traumatic brain injury market segments, market trends and opportunities, and any further data you may need to thrive in the traumatic brain injury industry. This traumatic brain injury market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Traumatic brain injury (TBI) is a type of injury caused by a sudden external force applied to the head, resulting in damage to the brain. Common causes of TBI include falls, motor vehicle accidents, sports-related injuries, and incidents of violence or military combat. Treatment for traumatic brain injuries involves a multidisciplinary approach, encompassing medical interventions, rehabilitation, and cognitive therapy.

The main devices used in traumatic brain injury management include computed tomography (CT), X-ray, other imaging devices, magnetic resonance imaging (MRI) devices, monitoring devices, and more. Computed tomography is a medical imaging method that employs specialized X-ray equipment to produce detailed cross-sectional images of the body. Techniques such as intracranial pressure (ICP) monitoring and measurement of partial pressure of oxygen in brain tissue (PbtO2) are used in hospitals, diagnostic centers, and other healthcare settings.

The traumatic brain injury market consists of revenues earned by entities by providing services such as rehabilitation services, medical care, counseling, psychological support, case management and recreational therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The traumatic brain injury market also includes sales of assistive devices, cognitive rehabilitation tools, communication aids and safety equipment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.